Monocytosis at Diagnosis Is Associated with Decreased Overall Survival in Patients with Newly Diagnosed Multiple Myeloma

被引：0
|
作者：
Edwards, Camille V.
Yildirim, Cenk
Fillmore, Nathanael
Munshi, Nikhil C.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141584
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
    Zhang, Yue
    Chen, Xiao-Lei
    Chen, Wen-Ming
    Zhou, He-Bing
    [J]. BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [2] Body Mass Index and Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
    Wang, Bei
    Derman, Benjamin A.
    Langerman, Spencer S.
    Johnson, Julie
    Zhang, Wei
    Jakubowiak, Andrzej
    Chiu, Brian C-H
    [J]. CANCERS, 2022, 14 (21)
  • [3] Prognostic nomogram incorporating cytokines for overall survival in patients with newly diagnosed multiple myeloma
    Cheng, Qianwen
    Zhao, Fei
    Zhang, Bo
    Zhang, Yuyang
    Cai, Li
    Qiao, Bing
    Hu, Yu
    Sun, Chunyan
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 99
  • [4] Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myeloma
    Strasser-Weippl, Kathrin
    Ludwig, Heinz
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 81 (05) : 374 - 379
  • [5] Shifts in the Therapeutic Paradigm for Patients Newly Diagnosed with Multiple Myeloma: Maintenance Therapy and Overall Survival
    Palumbo, Antonio
    Attal, Michel
    Roussel, Murielle
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (06) : 1253 - 1263
  • [6] THE FREQUENCY OF CYTOGENETIC ABNORMALITIES AND THEIR IMPACT ON OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA.
    Garifullin, A.
    Voloshin, S.
    Martynkevich, I.
    Bessmeltsev, S.
    Martynenko, L.
    Kleina, E.
    Salogub, G.
    Karyagina, E.
    Schmidt, A.
    Kuvshinov, A.
    Abdulkadyrov, K.
    [J]. HAEMATOLOGICA, 2015, 100 : 733 - 733
  • [7] KRAS but not NRAS mutations are associated with a favorable overall survival in newly diagnosed multiple myeloma patients treated with intensive therapy
    Langer, C.
    Roehner, L.
    Dolnik, A.
    Held, S.
    Kull, M.
    Teleanu, V
    Bunjes, D.
    Miller, D.
    Koepff, S.
    Schreder, M.
    Straka, C.
    Muegge, L-O
    Engelhardt, M.
    Bassermann, F.
    Doehner, H.
    Bargou, R. C.
    Einsele, H.
    Bullinger, L.
    Knop, S.
    Kroenke, J.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 183 - 183
  • [8] Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population
    Sorrig, Rasmus
    Klausen, Tobias W.
    Salomo, Morten
    Vangsted, Annette J.
    Frolund, Ulf Christian
    Andersen, Kristian T.
    Klostergaard, Anja
    Helleberg, Carsten
    Pedersen, Robert S.
    Pedersen, Per T.
    Helm-Petersen, Sissel
    Teodorescu, Elena Manuela
    Preiss, Birgitte
    Abildgaard, Niels
    Gimsing, Peter
    [J]. PLOS ONE, 2017, 12 (12):
  • [9] RECOMBINANT HUMAN ERYTHROPOIETIN IS ASSOCIATED WITH REDUCED OVERALL SURVIVAL IN NEWLY DIAGNOSED PATIENTS WITH MULTIPLE MYELOMA: A SINGLE CENTER EXPERIENCE IN 312 PATIENTS
    Katodritou, E.
    Verrou, E.
    Hadjiaggelidou, C.
    Gastari, V.
    Spyrou, A.
    Konstantinidou, P.
    Lazaridou, A.
    Konstantinou, N.
    Zervas, K.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 437 - 437
  • [10] Serum Free Light Chain Predict Overall Survival and Response to Therapy in Patients with Newly Diagnosed Multiple Myeloma
    Meddour, Yanis
    Rahali, Momahed C.
    Belakehal, Salah E.
    Ardjoun, Fatma Z.
    Chaib, Samia
    Djidjik, Reda
    [J]. CLINICAL LABORATORY, 2018, 64 (04) : 551 - 558
12345